112 related articles for article (PubMed ID: 18027384)
41. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
42. Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications.
Morita M; Masuda T; Okada S; Yoshinaga K; Saeki H; Tokunaga E; Endo K; Emi Y; Kakeji Y; Maehara Y
Anticancer Res; 2009 Jul; 29(7):2555-62. PubMed ID: 19596928
[TBL] [Abstract][Full Text] [Related]
43. Esophageal cancer.
Ajani JA; Barthel JS; Bekaii-Saab T; Bentrem DJ; D'Amico TA; Fuchs CS; Gerdes H; Hayman JA; Hazard L; Ilson DH; Kleinberg LR; McAleer MF; Meropol NJ; Mulcahy MF; Orringer MB; Osarogiagbon RU; Posey JA; Sasson AR; Scott WJ; Shibata S; Strong VE; Swisher SG; Washington MK; Willett C; Wood DE; Wright CD; Yang G;
J Natl Compr Canc Netw; 2008 Oct; 6(9):818-49. PubMed ID: 18926093
[No Abstract] [Full Text] [Related]
44. Preoperative therapy in esophageal cancer.
Ku GY; Ilson DH
Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
[TBL] [Abstract][Full Text] [Related]
45. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus.
Onozawa M; Nihei K; Ishikura S; Minashi K; Yano T; Muto M; Ohtsu A; Ogino T
Radiother Oncol; 2009 Aug; 92(2):266-9. PubMed ID: 18952308
[TBL] [Abstract][Full Text] [Related]
46. Transhiatal esophageal surgery for malignancy--a 7-year experience at a tertiary care hospital.
Qureshi AU; Iqbal M; Gondal KM
J Coll Physicians Surg Pak; 2009 Jul; 19(7):413-6. PubMed ID: 19576147
[TBL] [Abstract][Full Text] [Related]
47. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer (Br J Surg 2008; 95: 191-194).
Andriessen MJ; van der Peet DL; Cuesta MA
Br J Surg; 2008 Oct; 95(10):1305-6; author reply 1306. PubMed ID: 18763266
[No Abstract] [Full Text] [Related]
48. [Concurrent standard dose of cisplatin, paclitaxel, and radiotherapy followed by surgery in treatment of thoracic esophageal carcinoma].
Jiang YY; Wu SX; Zhang P; Xie CY; Wang J; Sun CC
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2171-4. PubMed ID: 19080664
[TBL] [Abstract][Full Text] [Related]
49. Adenocarcinoma of the proximal esophagus: report of 9 patients and review of the literature.
Marano S; Ruol A; Castoro C; Portale G; Cagol M; Alfieri R; Michieletto S; Ancona E
Ann Surg Oncol; 2008 Oct; 15(10):2910-4. PubMed ID: 18696159
[TBL] [Abstract][Full Text] [Related]
50. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
Javeri H; Arora R; Correa AM; Hofstetter WL; Lee JH; Liao Z; McAleer MF; Maru D; Bhutani MS; Swisher SG; Izzo JG; Ajani JA
Cancer; 2008 Sep; 113(6):1302-8. PubMed ID: 18623381
[TBL] [Abstract][Full Text] [Related]
51. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
[TBL] [Abstract][Full Text] [Related]
52. Management of thoracic duct injuries after oesophagectomy (Br J Surg 2001: 88: 1442-8). Letter 2.
Shackcloth M; McCarron E; Poullis M; Page R
Br J Surg; 2002 Jun; 89(6):809. PubMed ID: 12078651
[No Abstract] [Full Text] [Related]
53. Oesophagectomy - lessons from China.
Alderson D
Br J Surg; 2004 Jan; 91(1):4-5. PubMed ID: 14716787
[No Abstract] [Full Text] [Related]
54. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Chang KH; McAnena OJ
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):253; author reply 253-4. PubMed ID: 19154939
[No Abstract] [Full Text] [Related]
55. Transhiatal oesophagectomy: treatment of choice for high-grade dysplasia.
Mirnezami R; Rohatgi A; Sutcliffe RP; Hamouda A; Mason RC
Eur J Cardiothorac Surg; 2009 Aug; 36(2):364-7. PubMed ID: 19464917
[TBL] [Abstract][Full Text] [Related]
56. Role of neoadjuvant therapy for esophageal adenocarcinoma.
Ku GY; Ilson DH
Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
[TBL] [Abstract][Full Text] [Related]
57. Treatment of oesophageal squamous cell carcinoma in a patient with Fanconi anaemia.
Tipples K; Raouf S
Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):383-4. PubMed ID: 18387792
[No Abstract] [Full Text] [Related]
58. Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy.
Hsu FM; Lee YC; Lee JM; Hsu CH; Lin CC; Tsai YC; Wu JK; Cheng JC
Ann Surg Oncol; 2009 Jun; 16(6):1669-77. PubMed ID: 19267157
[TBL] [Abstract][Full Text] [Related]
59. Management of thoracic duct injuries after oesophagectomy (Br J Surg 2001: 88: 1442-8). Letter 1.
Guillem P; Triboulet JP
Br J Surg; 2002 Jun; 89(6):809. PubMed ID: 12028002
[No Abstract] [Full Text] [Related]
60. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
Mariette C; Piessen G; Briez N; Triboulet JP
Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
